Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease

Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for blood cancers and other haematological disorders. However, allo-HSCT leads to graft-versus-host disease (GVHD), a severe and often lethal immunological response, in the majority of transplant recipients. Curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuthbertson, Peter, Geraghty, Nicholas J., Adhikary, Sam R., Bird, Katrina M., Fuller, Stephen J., Watson, Debbie, Sluyter, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348324/
https://www.ncbi.nlm.nih.gov/pubmed/34361109
http://dx.doi.org/10.3390/ijms22158343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348324/
https://www.ncbi.nlm.nih.gov/pubmed/34361109
http://dx.doi.org/10.3390/ijms22158343

Ejemplares similares